Researchers find link between cancer, diabetes drugs and reduced risk of Alzheimer's disease

July 24, 2013 by Delthia Ricks, Newsday

People who have endured chemotherapy for some cancers appear to have a lower incidence of Alzheimer's disease, as do long-term users of a commonly prescribed diabetes drug, scientists have found in separate medical investigations.

Both research projects are opening new windows, some experts said, on how unrelated diseases and unexpected medications may have a protective impact on the brain.

No one wants to develop cancer and undergo , or, for that matter, take a potent diabetes medication to avoid Alzheimer's, said Dr. Gisele Wolf-Klein, a geriatrician and expert in Alzheimer's disease with the North Shore-Long Island Jewish Health System.

But the take-home message, she said, is that Alzheimer's is extraordinarily complex, and the new research helps reveal people at lower risk.

"Any study on Alzheimer's disease that is presented at a recognized national meeting is of interest because it raises public awareness and awareness in the scientific world," said Wolf-Klein, who was not involved in either of the new investigations. The two studies were presented at the Alzheimer's Association International Conference in Boston this week.

The research involved 3.5 million former members of the U.S. military who were treated for a variety of conditions in the Veterans' Administration health care system between 1996 and 2011, and were free of dementia when admitted.

Dr. Laura Frain, a geriatrician at the VA Boston Healthcare System, said the aim of her research was to evaluate the relationship between 19 different cancers, and Alzheimer's disease.

Among the cancers she evaluated were many of the most common - breast, prostate, lung and colorectal malignancies. She also examined cancers of the blood and lymphatic tissue. Patients were 65 and older.

Her research revealed that chemotherapy provided added protection against .

During the six years veterans were tracked, 82,028 were diagnosed with Alzheimer's. Yet, only 24 percent of them had a history of cancer compared with 76 percent who were never treated for a .

The research revealed a reduced Alzheimer's risk by as much as half for some forms of cancer. For example, there was a 51 percent lowered risk of Alzheimer's for liver cancer survivors; a 44 percent reduced risk for vets treated for pancreatic cancer, and a 25 percent lowered risk for those who had lung cancer.

"These findings indicate that the protective relationship between most cancers and Alzheimer's disease is not simply explained by increased mortality," Frain said, adding that more research is needed to find the underlying mechanism that spared patients' minds.

Yet, some forms of cancer and chemotherapy conferred no protective effect at all, clouding any evolving theory that in general and all forms of chemo protect the brain.

Cancers in which the Alzheimer's risk increased included melanoma, prostate and colorectal malignancies.

In the second investigation, Rachel Whitmer and colleagues at Kaiser Permanente's research division in California, studied nearly 15,000 patients 55 and older with type 2 diabetes.

The team discovered that metformin, a widely prescribed diabetes medication, reduced the risk of Alzheimer's by 20 percent.

Wolf-Klein said diabetes itself is a long-known risk factor for Alzheimer's disease.

But Whitmer noted that animal models suggest that metformin may aid in the development of new brain cells, which may, in turn, offset the damaging effects of the diabetes.

Explore further: People with Alzheimer's disease may have lower risk of cancer and vice versa

Related Stories

People with Alzheimer's disease may have lower risk of cancer and vice versa

July 10, 2013
Older people with Alzheimer's disease are less likely to also have cancer, and older people with cancer are less likely to also have Alzheimer's disease, according to the largest study to date on the topic, which appears ...

Diabetes drug may protect the brain

July 15, 2013
(HealthDay)—The diabetes drug metformin may do more than help control blood sugar levels: New research suggests it may also reduce the risk of dementia.

Skin cancer may be linked to lower risk of Alzheimer's disease

May 15, 2013
People who have skin cancer may be less likely to develop Alzheimer's disease, according to new research published in the May 15, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology. ...

Gene discovery offers new path for Alzheimer's research

July 9, 2013
A new gene variant has been linked to Alzheimer's disease, and this association is strongest among elderly blacks.

Nonmelanoma skin cancer tied to lower Alzheimer's risk

May 16, 2013
(HealthDay)—Older individuals with nonmelanoma skin cancer (NMSC) seem to have a significantly reduced risk of developing Alzheimer's disease (AD), according to a study published online May 15 in Neurology.

Highest risk Alzheimer's genetic carriers take positive steps after learning risk status

July 16, 2013
People who found out they carried an uncommon genetic risk for Alzheimer's disease did not experience more anxiety, depression or distress than non-carriers, and were more active in efforts to reduce their risk of Alzheimer's ...

Recommended for you

Alzheimer's disease: Neuronal loss very limited

January 17, 2018
Frequently encountered in the elderly, Alzheimer's is considered a neurodegenerative disease, which means that it is accompanied by a significant, progressive loss of neurons and their nerve endings, or synapses. A joint ...

Anxiety: An early indicator of Alzheimer's disease?

January 12, 2018
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of ...

One of the most promising drugs for Alzheimer's disease fails in clinical trials

January 11, 2018
To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

Different disease types associated with distinct amyloid-beta prion strains found in Alzheimer's patients

January 9, 2018
An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National ...

Advances in brain imaging settle debate over spread of key protein in Alzheimer's

January 5, 2018
Recent advances in brain imaging have enabled scientists to show for the first time that a key protein which causes nerve cell death spreads throughout the brain in Alzheimer's disease - and hence that blocking its spread ...

Molecular mechanism behind HIV-associated dementia revealed

January 5, 2018
For the first time, scientists have identified and inhibited a molecular process that can lead to neurodegeneration in patients with HIV, according to a Northwestern Medicine study published in Nature Communications.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.